Fullstack Developer
Appnovation Technologies7 hours ago
Toronto, CanadaMid Level
Responsibilities
- Build and maintain end-to-end frontend and backend features.
- Integrate digital health devices, wearables, sensors, and third-party services into the platform.
- Write well-tested code and test work before it reaches QA.
- Document features, integrations, and technical decisions while sharing knowledge with the team.
- Follow privacy and compliance requirements for personal health data.
- Translate well-formed stories into working software, participate in code reviews, and raise risks or blockers early.
Requirements
- At least 4 years of professional full stack development experience.
- Ability to work independently from well-defined stories and recognize when to ask for help.
- Clear written communication and ability to document work.
- Experience with React, Next.js, TypeScript, Python, and Node.js.
- Experience integrating digital health devices and communication protocols such as Bluetooth Low Energy is preferred.
- Experience in health, life sciences, regulated industries, sensitive personal data, or consulting and agency environments is preferred.
Benefits
- Challenging work with real impact and exposure to high-profile clients.
- Direct access to cutting-edge AI platforms.
- Diverse, inclusive, collaborative, and innovative work environment.
- Growth opportunities for personal and professional development.
- Supportive environment with access to company leaders.
- Hybrid working model.
Tech Stack
Categories
About Appnovation Technologies
Appnovation Technologies is a privately held digital consultancy that designs, builds, and supports customer-facing platforms for enterprises, combining strategy, UX, engineering, and managed services. Its teams deliver web and mobile development, Drupal and open-source implementations, Atlassian consulting, and data/AI-enabled solutions for large organizations. Founded in 2007 and headquartered in Vancouver, it serves global clients including Pfizer, Google, Yeti, TCL, and AstraZeneca.